NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $162,000 | -60.1% | 30,062 | 0.0% | 0.00% | -57.1% |
| Q4 2021 | $406,000 | -24.8% | 30,062 | 0.0% | 0.01% | -30.0% |
| Q3 2021 | $540,000 | +4.7% | 30,062 | 0.0% | 0.01% | +11.1% |
| Q2 2021 | $516,000 | -14.1% | 30,062 | 0.0% | 0.01% | -10.0% |
| Q1 2021 | $601,000 | +280.4% | 30,062 | +539.6% | 0.01% | +233.3% |
| Q1 2019 | $158,000 | -64.2% | 4,700 | -50.0% | 0.00% | -40.0% |
| Q4 2018 | $441,000 | +53.7% | 9,400 | +100.0% | 0.01% | -16.7% |
| Q3 2018 | $287,000 | +15.3% | 4,700 | -7.8% | 0.01% | +20.0% |
| Q2 2018 | $249,000 | – | 5,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |